Slingshot members are tracking this event:

Sangamo Therapeutics (SGMO) to submit IND in 2018 for cDNA gene therapy, which is designed to treat Fabry disease

Do you think this event is important to the companies below? How will it affect their stock price?

Related Companies
High Medium Low
Impact on Stocks
SGMO Community voting in process
Slingshot Insights Explained
Related Projects Image
  • Don’t see a project related to the catalyst you care about?

Related Keywords Cdna, Fabry Disease, Ind Filing